These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 16298265)

  • 1. Creatinine clearance and hemoglobin concentration before and after heart transplantation.
    Cirillo M; De Santo LS; Pollastro RM; Romano G; Mastroianni C; Maiello C; Amarelli C; Di Stazio E; Perna A; Anastasio P
    Semin Nephrol; 2005 Nov; 25(6):413-8. PubMed ID: 16298265
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mild vs severe pulmonary hypertension before heart transplantation: different effects on posttransplantation pulmonary hypertension and mortality.
    Chang PP; Longenecker JC; Wang NY; Baughman KL; Conte JV; Hare JM; Kasper EK
    J Heart Lung Transplant; 2005 Aug; 24(8):998-1007. PubMed ID: 16102433
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hemoglobin level, chronic kidney disease, and the risks of death and hospitalization in adults with chronic heart failure: the Anemia in Chronic Heart Failure: Outcomes and Resource Utilization (ANCHOR) Study.
    Go AS; Yang J; Ackerson LM; Lepper K; Robbins S; Massie BM; Shlipak MG
    Circulation; 2006 Jun; 113(23):2713-23. PubMed ID: 16754803
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ischaemic heart disease is a risk factor for renal failure after heart transplantation.
    Hosková L; Viklický O; Málek I; Podzimková M; Hegarová M; Pirk J; Vítko S; Kautzner J
    Int J Cardiol; 2008 Jan; 123(3):358-60. PubMed ID: 17360057
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Usefulness of heart rate as an independent predictor for survival after heart transplantation.
    Anand RG; Reddy MT; Yau CL; Myers L; Amin RR; Stahls PF; Dumas D; Frohlich ED; Ventura HO
    Am J Cardiol; 2009 May; 103(9):1290-4. PubMed ID: 19406274
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pre-transplant risk factors for chronic renal dysfunction after pediatric heart transplantation: a 10-year national cohort study.
    Lee CK; Christensen LL; Magee JC; Ojo AO; Harmon WE; Bridges ND
    J Heart Lung Transplant; 2007 May; 26(5):458-65. PubMed ID: 17449414
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevated serum uric acid levels following heart transplantation predict all-cause and cardiac mortality.
    Arora S; Aukrust P; Ueland T; Broch K; Simonsen S; Gude E; Fiane AE; Geiran O; Wergeland R; Andreassen AK; Gullestad L
    Eur J Heart Fail; 2009 Oct; 11(10):1005-13. PubMed ID: 19737803
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of methods for determining renal function decline in early autosomal dominant polycystic kidney disease: the consortium of radiologic imaging studies of polycystic kidney disease cohort.
    Rule AD; Torres VE; Chapman AB; Grantham JJ; Guay-Woodford LM; Bae KT; Klahr S; Bennett WM; Meyers CM; Thompson PA; Miller JP;
    J Am Soc Nephrol; 2006 Mar; 17(3):854-62. PubMed ID: 16452494
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors associated with long-term survival following cardiac transplantation.
    Sareyyüpoğlu B; Kirali K; Göksedef D; Rabuş MB; Tuncer A; Erentuğ V; Mansuroğlu D; Yakut C
    Anadolu Kardiyol Derg; 2008 Oct; 8(5):360-6. PubMed ID: 18849228
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pulmonary vascular remodeling in pulmonary hypertension due to chronic heart failure.
    Delgado JF; Conde E; Sánchez V; López-Ríos F; Gómez-Sánchez MA; Escribano P; Sotelo T; Gómez de la Cámara A; Cortina J; de la Calzada CS
    Eur J Heart Fail; 2005 Oct; 7(6):1011-6. PubMed ID: 16227139
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renal function and serum albumin at the start of dialysis in 514 Chinese ESRD in-patients.
    Liu H; Peng Y; Liu F; Xiao H; Chen X; Huang A; Liu Y
    Ren Fail; 2008; 30(7):685-90. PubMed ID: 18704816
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors influencing renal function after liver transplantation. Results from the MOST, an international observational study.
    Burra P; Senzolo M; Masier A; Prestele H; Jones R; Samuel D; Villamil F
    Dig Liver Dis; 2009 May; 41(5):350-6. PubMed ID: 19046932
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cystatin C as a marker of renal function immediately after liver transplantation.
    Biancofiore G; Pucci L; Cerutti E; Penno G; Pardini E; Esposito M; Bindi L; Pelati E; Romanelli A; Triscornia S; Salvadorini MP; Stratta C; Lanfranco G; Pellegrini G; Del Prato S; Salizzoni M; Mosca F; Filipponi F
    Liver Transpl; 2006 Feb; 12(2):285-91. PubMed ID: 16447198
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Morbidity, mortality and economic burden of renal impairment in cardiac intensive care.
    Chew DP; Astley C; Molloy D; Vaile J; De Pasquale CG; Aylward P
    Intern Med J; 2006 Mar; 36(3):185-92. PubMed ID: 16503954
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of ventricular assist devices on post-transplant mortality an analysis of the United network for organ sharing thoracic registry.
    Patlolla V; Patten RD; Denofrio D; Konstam MA; Krishnamani R
    J Am Coll Cardiol; 2009 Jan; 53(3):264-71. PubMed ID: 19147043
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cystatin C in acute heart failure without advanced renal impairment.
    Naruse H; Ishii J; Kawai T; Hattori K; Ishikawa M; Okumura M; Kan S; Nakano T; Matsui S; Nomura M; Hishida H; Ozaki Y
    Am J Med; 2009 Jun; 122(6):566-73. PubMed ID: 19393984
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of survival by allocation to medical therapy, surgery, or heart transplantation for ischemic advanced heart failure.
    Lim E; Ali Z; Ali A; Motalleb-Zadeh R; Jackson C; Ong SL; Halstead J; Sharples L; Parameshwar J; Wallwork J; Large SR
    J Heart Lung Transplant; 2005 Aug; 24(8):983-9. PubMed ID: 16102430
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of pre- and post-transplant anemia on 1-year survival after cardiac transplantation.
    Taegtmeyer AB; Rogers P; Breen JB; Barton PJ; Banner NR; Yacoub MH
    J Heart Lung Transplant; 2008 Apr; 27(4):394-9. PubMed ID: 18374875
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcomes in patients older than 60 years of age undergoing orthotopic heart transplantation: an analysis of the UNOS database.
    Weiss ES; Nwakanma LU; Patel ND; Yuh DD
    J Heart Lung Transplant; 2008 Feb; 27(2):184-91. PubMed ID: 18267225
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum neutrophil gelatinase-associated lipocalin as a marker of renal function in non-diabetic patients with stage 2-4 chronic kidney disease.
    Malyszko J; Bachorzewska-Gajewska H; Sitniewska E; Malyszko JS; Poniatowski B; Dobrzycki S
    Ren Fail; 2008; 30(6):625-8. PubMed ID: 18661413
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.